NTRA
Natera, Inc. · Healthcare · Medical - Diagnostics & Research
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 215.03K | $85.48M | n/a | −2 |
| Q2 2026 | 160 | 0 | 103.68M | $28.12B | +5 | −6 |
| Q1 2026 | 164 | +3 | 98.65M | $19.54B | +6 | −4 |
| Q4 2025 | 160 | 0 | 102.31M | $23.44B | +1 | n/a |
| Q3 2025 | 23 | +1 | 81.70M | $13.15B | +1 | −1 |
| Q2 2025 | 20 | -1 | 57.32M | $9.68B | n/a | −1 |
| Q1 2025 | 18 | 0 | 31.15M | $4.40B | n/a | n/a |
| Q4 2024 | 18 | 0 | 26.97M | $4.27B | n/a | n/a |
| Q3 2024 | 17 | -1 | 21.42M | $2.72B | n/a | −1 |
| Q2 2024 | 18 | n/a | 16.29M | $1.76B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 3.05M | n/a | $330.06M | 0.3% | n/c | 1 | SEC ↗ ×3 |
| 2 | Duquesne Family Office ✦ | 1.97M | n/a | $213.86M | 7.6% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 1.95M | n/a | $210.86M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 1.67M | n/a | $181.30M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (pasif) | 1.32M | n/a | $142.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 1.15M | n/a | $124.03M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 958.38K | n/a | $103.78M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 8 | Wellington Management ✦ | 916.78K | n/a | $99.28M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | AQR Capital Management ✦ | 651.52K | n/a | $70.55M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 10 | Point72 Asset Management ✦ | 561.94K | n/a | $60.85M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 528.81K | n/a | $57.27M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | ARK Investment Management ✦ | 415.34K | n/a | $44.98M | 0.4% | n/c | 1 | SEC ↗ |
| 13 | Capital World Investors ✦ | 396.42K | n/a | $42.93M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 331.98K | n/a | $35.95M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 216.50K | n/a | $23.44M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Soros Fund Management ✦ | 100.00K | n/a | $10.83M | 0.3% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 86.42K | n/a | $9.36M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 21.53K | n/a | $2.33M | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 755 pemegang, 120.14M saham, $20.15B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 60 lbr · $24,097
Director · 35 lbr · $14,232
Director · 80 lbr · $32,484
Director · 90 lbr · $36,333
Director · 142 lbr · $56,651
Director · 280 lbr · $112,189
Director · 80 lbr · $32,749
Director · 50 lbr · $20,258
Director · 215 lbr · $85,858
Director · 98 lbr · $40,116
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi